Evidence map›Paper›PMID 22422706›Full record

ArticleCytoskeleton (Hoboken, N.J.)2012

Control of MCAK degradation and removal from centromeres.

Anutosh Ganguly, Rajat Bhattacharya, Fernando Cabral

Open access · greenAbstract read
In one paragraph

Article in Cytoskeleton (Hoboken, N.J.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Anutosh GangulyDepartment of Integrative Biology and Pharmacology, University of Texas Medical School, Houston, Texas 77030, USA.
Rajat Bhattacharya
Fernando Cabral
The University of Texas at Austin · USThe University of Texas Health Science Center at Houston · US

Funding

TUBULIN MUTATIONS AND PACLITAXEL RESISTANCER01CA085935 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CABRAL, FERNANDO R · 2000 to 2010
$2.7M
NCI NIH HHS CA85935NCI NIH HHS R01 CA085935
6 · The paper itself

Abstract

Mitotic centromere associated kinesin (MCAK) is a kinesin related protein with the ability to stimulate microtubule depolymerization. It is found at spindle poles, where it may be involved in poleward microtubule flux, and at kinetochores and centromeres where it plays a role in correcting chromosome alignment errors. Its microtubule depolymerase activity and recruitment to centromeres is regulated by phosphorylation, but little is known about how MCAK is maintained at appropriate levels. We previously reported that MCAK accumulates during the cell cycle and is then degraded during mitosis. Using proteomic analysis, we have now identified a new phosphorylation site on MCAK that is responsible for its degradation. Mutation of the site to prevent phosphorylation prolonged the stability of the protein beyond the metaphase to anaphase transition and into the subsequent cell cycle whereas a phosphomimetic mutation accelerated degradation. Unexpectedly, the mutation that prevented phosphorylation also inhibited the removal of MCAK from centromeres causing it to remain attached throughout the cell cycle. Even low expression of phosphorylation-resistant MCAK delayed mitosis and interfered with cell division. Mitotic defects were also observed by overexpressing a green fluorescent protein-tagged version of wild-type MCAK that similarly escaped degradation and accumulated to toxic levels, but did not remain associated with kinetochores during interphase. The results demonstrate that degradation is an important mechanism for controlling the activity of MCAK.

Indexed as

ProteomicsAnimalsCell CycleCentromereCHO CellsCricetinaeElectrophoretic Mobility Shift AssayFluorescent Antibody TechniqueHumansImmunoprecipitationKinesinsKinetochoresMitosisMutagenesis, Site-DirectedMutationPhosphorylationKIF2C protein, humanKinesins

Identifiers

PMID22422706
PMCPMC3390786
OpenAlexW2043401889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.